Menu
Back to User profile » Dr Yiru Fang
Papers published by Dr Yiru Fang:
Functional Alterations in Patients with Bipolar Disorder and Their Unaffected First-Degree Relatives: Insight from Genetic, Epidemiological, and Neuroimaging Data
Zhang H, Chen J, Fang Y
Neuropsychiatric Disease and Treatment 2023, 19:2797-2806
Published Date: 14 December 2023
Clinical Guideline (CANMAT 2016) Discordance of Medications for Patients with Major Depressive Disorder in China
Zhu Y, Wu Z, Zhao D, Wu X, He R, Wang Z, Peng D, Fang Y
Neuropsychiatric Disease and Treatment 2023, 19:829-839
Published Date: 12 April 2023
Validation of the THINC-It Tool for Assessment of Cognitive Impairment in Patients with Bipolar Depression
Zhu N, Zhang W, Huang J, Su Y, Lu J, Yang L, Shi Y, Hu S, Chen J, Fang Y
Neuropsychiatric Disease and Treatment 2023, 19:443-452
Published Date: 27 February 2023
A Preliminary Study of Different Treatment Strategies for Anxious Depression
Wang Y, Liu X, Peng D, Wu Y, Su Y, Xu J, Ma X, Li Y, Shi J, Cheng X, Rong H, Fang Y
Neuropsychiatric Disease and Treatment 2022, 18:11-18
Published Date: 4 January 2022
A Preliminary Randomized Controlled Trial of Different Treatment Regimens for Melancholic Depression
Wang Y, Liu X, Peng D, Wu Y, Su Y, Xu J, Ma X, Li Y, Shi J, Cheng X, Rong H, Fang Y
Neuropsychiatric Disease and Treatment 2021, 17:2441-2449
Published Date: 23 July 2021
Exploring the Effects of Temperament on Gray Matter Volume of Frontal Cortex in Patients with Mood Disorders
Yang T, Lam RW, Huang J, Su Y, Liu J, Yang X, Yang L, Zhu N, Zhao G, Mao R, Zhou R, Xia W, Liu H, Wang Z, Chen J, Fang Y
Neuropsychiatric Disease and Treatment 2021, 17:183-193
Published Date: 22 January 2021
Reliability and Validity of THINC-it in Evaluating Cognitive Function of Patients with Bipolar Depression
Zhang W, Zhu N, Lai J, Liu J, Ng CH, Chen J, Qian C, Du Y, Hu C, Chen J, Hu J, Wang Z, Zhou H, Xu Y, Fang Y, Shi C, Hu S
Neuropsychiatric Disease and Treatment 2020, 16:2419-2428
Published Date: 21 October 2020
The Developmental and Translational Study on Biomarkers and Clinical Characteristics-based Diagnostic and Therapeutic Identification of Major Depressive Disorder: Study Protocol for a Multicenter Randomized Controlled Trial in China
Liu X, Wang Y, Peng D, Zhang HZ, Zheng Y, Wu Y, Su YA, Liu M, Ma X, Li Y, Shi J, Cheng X, Rong H, Fang Y
Neuropsychiatric Disease and Treatment 2020, 16:2343-2351
Published Date: 9 October 2020
Lack of Association Between PLA2G6 Genetic Variation and Parkinson’s Disease: A Systematic Review
Liu H, Yao Y, Liu H, Peng Y, Ren J, Wu X, Mao R, Zhao J, Zhu Y, Niu Z, Yang T, Sun X, Jiang P, Zhang C, Fang Y
Neuropsychiatric Disease and Treatment 2020, 16:1755-1763
Published Date: 23 July 2020
Variants in the Upstream Region of the Insulin Receptor Substrate-1 Gene Is Associated with Major Depressive Disorder in the Han Chinese Population
Wang F, Yu S, Zhou R, Mao R, Zhao G, Guo X, Xu Q, Chen J, Zhang C, Fang Y
Neuropsychiatric Disease and Treatment 2020, 16:501-507
Published Date: 20 February 2020
Cognitive symptoms in major depressive disorder: associations with clinical and functional outcomes in a 6-month, non-interventional, prospective study in China
Wang G, Si TM, Li L, Fang Y, Wang CX, Wang LN, Tan KHX, Ettrup A, Eriksen HLF, Luo S, Ge L
Neuropsychiatric Disease and Treatment 2019, 15:1723-1736
Published Date: 1 July 2019
Clinical outcomes of patients with major depressive disorder treated with either duloxetine, escitalopram, fluoxetine, paroxetine, or sertraline
Huang J, Wang Y, Chen J, Zhang Y, Yuan Z, Yue L, Haro JM, Moneta MV, Novick D, Fang YR
Neuropsychiatric Disease and Treatment 2018, 14:2473-2484
Published Date: 26 September 2018
Abnormal white matter integrity in Chinese young adults with first-episode medication-free anxious depression: a possible neurological biomarker of subtype major depressive disorder
Xia W, Zhou R, Zhao G, Wang F, Mao R, Peng D, Yang T, Wang Z, Chen J, Fang Y
Neuropsychiatric Disease and Treatment 2018, 14:2017-2026
Published Date: 10 August 2018